Effects of The Effects of Dietary Oils on Fasting Lipoprotein Lipids
Not Applicable
Completed
- Conditions
- Hypercholesterolemia
- Registration Number
- NCT01925716
- Lead Sponsor
- ACH Food Companies, Inc.
- Brief Summary
The objectives of this clinical trial are to assess the effects of dietary oils on blood lipids and other aspects of the fasting lipoprotein profile in healthy men and women with elevated cholesterol
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 57
Inclusion Criteria
- Fasting LDL-C level equal to or greater than 130 mg/dL and less than 200 mg/dL at visit 1
- Fasting triglycerides less than or equal to 350 mg/dL at visit 1
Exclusion Criteria
- Has coronary heart disease or coronary heart disease risk risk equivalent, such as diabetes, atherosclerosis, etc
- Taking lipid medications intended to alter the lipids profile, including but not limited to statins, bile acid sequestrants, etc.
- Uncontrolled hypertension (systolic greater than or equal to 160 mm Hg or diastolic greater than or equal to 100 mm Hg)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Low Density Lipoprotein cholesterol Time Frame: baseline (average days -7 and 0) and the end of each treatment period [Treatment 1 averages of days 19 and 21and Treatment II (average of days 19 and 21)]: patients are followed for an average of 11 weeks
- Secondary Outcome Measures
Name Time Method total cholesterol baseline (average of days -7 and 0) and the end of each treatment period [Treatment I average of days 19 and 21) and treatment II (average of days 19 and 21)]: patients are followed for an average of 11 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which dietary oils influence fasting lipoprotein lipid profiles in hypercholesterolemia patients?
How does the intervention in NCT01925716 compare to statin-based therapies in managing elevated cholesterol levels?
Are there specific biomarkers that correlate with changes in lipoprotein lipids following dietary oil interventions in hypercholesterolemia?
What adverse events are associated with long-term consumption of alternative dietary oils in hypercholesterolemic individuals?
What combination therapies with dietary oils show enhanced efficacy in lipid management compared to monotherapies for hypercholesterolemia?